Difference between revisions of "Part:BBa K1632023:Experience"

(→‎Materials and Methods)
(→‎Construction)
Line 7: Line 7:
 
All the samples were JM2.300 strain with antibiotic resistance to ampicillin and kanamycin.<br>
 
All the samples were JM2.300 strain with antibiotic resistance to ampicillin and kanamycin.<br>
  
−
A.Pcon_rhlR_TT_Plux_CmR (pSB6A1) + Plac_lasI (pSB3K3)<br>
+
(1) J23100_rhlR_TT_Plux_CmR (pSB6A1) + Plac_lasI (pSB3K3)<br>
−
B.Pcon_rhlR_TT_Plux_CmR (pSB6A1) +promotor_lasI (pSB3K3)<br>
+
(2) J23100_rhlR_TT_Plux_CmR (pSB6A1) +promotor_lasI (pSB3K3)<br>
−
C.Pcon_rhlR_TT_promotor_CmR (pSB6A1) + Plac_lasI (pSB3K3)…Negative control #1<br>
+
(3) J23100_rhlR_TT_promotor_CmR (pSB6A1) + Plac_lasI (pSB3K3)…Negative control #1<br>
−
D.Pcon_rhlR_TT_promotor_CmR (pSB6A1) +promotor_lasI (pSB3K3)…Negative control #2<br>
+
(4) J23100_rhlR_TT_promotor_CmR (pSB6A1) +promotor_lasI (pSB3K3)…Negative control #2<br>
−
E.Pcon_rhlR_TT_Plux_CmRssrA (pSB6A1) + Plac_lasI (pSB3K3)<br>
+
(5) J23100_rhlR_TT_Plux_CmRssrA (pSB6A1) + Plac_lasI (pSB3K3)<br>
−
F.Pcon_rhlR_TT_Plux_CmRssrA (pSB6A1) +promotor_lasI (pSB3K3)<br>
+
(6) J23100_rhlR_TT_Plux_CmRssrA (pSB6A1) +promotor_lasI (pSB3K3)<br>
  
 
[[Image:RhlR cmRssrA Assay Construction.png|thumb|center|600px|<b>Fig. 1. </b>Plasmids]]<br>
 
[[Image:RhlR cmRssrA Assay Construction.png|thumb|center|600px|<b>Fig. 1. </b>Plasmids]]<br>

Revision as of 19:19, 17 September 2015

J23100_rbs_rhlR_TT_Plux_rbs_CmRssrA

Materials and Methods

Construction

All the samples were JM2.300 strain with antibiotic resistance to ampicillin and kanamycin.

(1) J23100_rhlR_TT_Plux_CmR (pSB6A1) + Plac_lasI (pSB3K3)
(2) J23100_rhlR_TT_Plux_CmR (pSB6A1) +promotor_lasI (pSB3K3)
(3) J23100_rhlR_TT_promotor_CmR (pSB6A1) + Plac_lasI (pSB3K3)…Negative control #1
(4) J23100_rhlR_TT_promotor_CmR (pSB6A1) +promotor_lasI (pSB3K3)…Negative control #2
(5) J23100_rhlR_TT_Plux_CmRssrA (pSB6A1) + Plac_lasI (pSB3K3)
(6) J23100_rhlR_TT_Plux_CmRssrA (pSB6A1) +promotor_lasI (pSB3K3)

Fig. 1. Plasmids

Assay protocol

1.Prepare overnight cultures for the samples in 3 mL LB medium, containing ampicillin (50 microg/mL) and kanamycin (30 microg/mL) at 37°C for 12 hours.
2.Make a 1:100 dilution in 3 mL of fresh LB containing antibiotic and grow the cells at 37°C until the observed OD590 reaches 0.5.
3.Centrifuge 1 mL of the sample at 5000g, RT for 1 minute.
4.Suspend the pellet in 1mL of LB containing Amp and Kan.
5.Add 30 microL of suspension in the following medium.
a)LB (3 mL) + antibiotics (Amp 50 microg/mL + Kan 30 microg/mL) + 50 microL C4HSL (30 microL) + 99.5% ethanol (3 microL)
b)LB (3 mL) + antibiotics (Amp 50 microg/mL + Kan 30 microg/mL) + DMSO (30 microL) + 99.5% ethanol (3 microL)
c)LB (3 mL) + antibiotics (Amp 50 microg/mL + Kan 30 microg/mL) + 50 microL C4HSL (30 microL) + Chloramphenicol (100 microg/mL)
d)LB (3 mL) + antibiotics (Amp 50 microg/mL + Kan 30 microg/mL) + DMSO (30 microL) + Chloramphenicol (100 microg/mL)
6.Grow the samples of cells at 37°C for more than 8 hours.
7.Measure optical density every hour. (If the optical density is over 1.0, dilute the cell medium to 1/5.)

Results

Discussion

More information

For more information, see [http://2015.igem.org/Team:Tokyo_Tech/Project our work in Tokyo_Tech 2015 wiki].

More information

For more information, see [http://2015.igem.org/Team:Tokyo_Tech/Project our work in Tokyo_Tech 2015 wiki].

Applications of BBa_K1632023

User Reviews

UNIQ2f0ab7ea9baf6cb1-partinfo-00000001-QINU UNIQ2f0ab7ea9baf6cb1-partinfo-00000002-QINU